The DOI matches its Crossref record; 154 of the 156 references it cites were found in a registry or an index.
Sarcopenia: revised European consensus on definition and diagnosis
Open accessAbstract
Background: in 2010, the European Working Group on Sarcopenia in Older People (EWGSOP) published a sarcopenia definition that aimed to foster advances in identifying and caring for people with sarcopenia. In early 2018, the Working Group met again (EWGSOP2) to update the original definition in order to reflect scientific and clinical evidence that has built over the last decade. This paper presents our updated findings. Objectives: to increase consistency of research design, clinical diagnoses and ultimately, care for people with sarcopenia. Recommendations: sarcopenia is a muscle disease (muscle failure) rooted in adverse muscle changes that accrue across a lifetime; sarcopenia is common among adults of older age but can also occur earlier in life. In this updated consensus paper on sarcopenia, EWGSOP2: (1) focuses on low muscle strength as a key characteristic of sarcopenia, uses detection of low muscle quantity and quality to confirm the sarcopenia diagnosis, and identifies poor physical performance as indicative of severe sarcopenia; (2) updates the clinical algorithm that can be used for sarcopenia case-finding, diagnosis and confirmation, and severity determination and (3) provides clear cut-off points for measurements of variables that identify and characterise sarcopenia. Conclusions: EWGSOP2's updated recommendations aim to increase awareness of sarcopenia and its risk. With these new recommendations, EWGSOP2 calls for healthcare professionals who treat patients at risk for sarcopenia to take actions that will promote early detection and treatment. We also encourage more research in the field of sarcopenia in order to prevent or delay adverse health outcomes that incur a heavy burden for patients and healthcare systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These variables are critical indicators of mobility, independence, and fall risk in older adults [3].”
From Efficacy of Power Training on Sarcopenic Obesity in Community-Dwelling Older Women: A 32-Week Randomized Clinical Trial (2025) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These individuals—and especially women and those with T2D, prediabetes, or metabolic dysfunction‐associated steatotic liver disease (MASLD)—are already at high risk of sarcopenia (age‐related loss of skeletal muscle function and mass), 30 , 31 sarcopenic obesity (the co‐existence of excess adiposity and low muscle mass/function, which can occur at any age 32 ), and the serious negative health out”
From Strategies for minimizing muscle loss during use of incretin‐mimetic drugs for treatment of obesity (2025) · cites this paper as [28]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Sarcopenia definitions have evolved through European and Asian consensus updates that place greater emphasis on muscle strength and physical performance, while the ESPEN and EASO consensus and the Sarcopenic Obesity Global Leadership Initiative have attempted to standardize SO diagnosis and research priorities (2, 7–9).”
From Exercise-based interventions for sarcopenic obesity in middle-aged and older adults: an umbrella review of systematic reviews with pairwise meta-analyses and network meta-analyses (2026) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, a major reason for the variation in sarcopenic obesity prevalence is the method of adjusting muscle quantity for body size.46,47,55,57”
From Changes in lean body mass with glucagon‐like peptide ‐1‐based therapies and mitigation strategies (2024) · cites this paper as [46]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“All regional working groups on the definition of sarcopenia have moved from recommending using lean mass alone to adding muscle strength and function, and switching the focus of the definition from lean mass to muscle strength and function.[46][47][48]”
From Changes in lean body mass with glucagon‐like peptide ‐1‐based therapies and mitigation strategies (2024) · cites this paper as [46]
Experimental — accuracy not yet measured
The cited source says what the claim attributes to it.
In the citing paper
“The updated definition of sarcopenia elevated low muscle strength to the forefront as a primary indicator of sarcopenia and identified poor physical performance as indicative of severe sarcopenia (52).”
From Evolution of the diagnosis of malnutrition in adults: a primer for clinicians (2024) · cites this paper as [52]
In the citing paper
“In this revised consensus, low physical performance is proposed as an indicator of severe sarcopenia.”
From Health Consequences of Sarcopenic Obesity: A Narrative Review (2020) · cites this paper as [19]
In the citing paper
“Notably, the EWGSOP2 reported low muscle strength as a key characteristic of sarcopenia to facilitate the prompt identification of sarcopenia in practice (19).”
From Health Consequences of Sarcopenic Obesity: A Narrative Review (2020) · cites this paper as [19]
In the citing paper
“the updated EWGSOP2 guidelines that focused on low muscle strength using grip strength as a central factor for diagnosing sarcopenia, as muscle strength has been shown to better predict poor outcomes than muscle mass in sarcopenia (3–5).”
From Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management (2023) · cites this paper as [3]
In the citing paper
“Therefore, the adverse effects of sarcopenia on quality of life, health care demand, morbidity, and mortality can affect both middle‐aged and older‐aged adults. 1 , 2 , 6”
From Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysis (2022) · cites this paper as [1]
In the citing paper
“but the decline in muscle mass starts from ~40 years onwards. 1”
From Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysis (2022) · cites this paper as [1]
In the citing paper
“Sarcopenia is a progressive and complex disease associated with a higher burden of morbidity and mortality. 1 , 2 , 6”
From Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysis (2022) · cites this paper as [1]
In the citing paper
“The revised EWGSOP2 emphasizes that severe sarcopenia should be based on the combination of sarcopenia plus a low physical performance, such as slow gait speed. 1”
From Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysis (2022) · cites this paper as [1]
In the citing paper
“Nowadays, it is known that the decrease in muscle mass function and quality start at ~40 years and that sarcopenia often appears earlier in life. 1 , 2”
From Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysis (2022) · cites this paper as [1]
In the citing paper
“the biggest impact is likely to be on prevalence estimated using EWGSWOP2 1 as well as the AWGS that updated its sarcopenia definition and its cut‐off points in March 2020. 33”
From Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysis (2022) · cites this paper as [1]
In the citing paper
“although the effect of obesity on years-of-life-lost is greatest in younger adults, and the magnitude of years lost with obesity decreases with ageing [16], irrespective of sex, smoking status, physical activity level, or socioeconomic status [35]”
From Obesity pharmacotherapy in older adults: a narrative review of evidence (2025) · cites this paper as [35]
In the citing paper
“Sarcopenia, defined as low skeletal muscle mass and function, has been identified and described as a geriatric syndrome with a multifactorial aetiology whose prevalence increases with age [3-5].”
From Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement (2022) · cites this paper as [5]
In the citing paper
“This definition was revised in 2019 to describe sarcopenia as “a muscle disease originating from adverse muscle changes that accumulate over a lifetime”.”
From Imaging of Sarcopenia in Type 2 Diabetes Mellitus (2024) · cites this paper as [1]
In the citing paper
“The recent guidelines from EWGSOP have made slight modifications to previous diagnostic cutoff values, proposing an ALMI < 5.5 kg/m2 in women and ALMI < 7.0 kg/m2 in men be used as criteria for defining low muscle mass (1).”
From Imaging of Sarcopenia in Type 2 Diabetes Mellitus (2024) · cites this paper as [1]
In the citing paper
“EWGSOP proposes a screening and diagnostic approach for sarcopenia termed “Find-Assess-Confirm-Severity” (F-A-C-S; Figure 1).1”
From Imaging of Sarcopenia in Type 2 Diabetes Mellitus (2024) · cites this paper as [1]
In the citing paper
“Among the strategies for preserving muscle quantity and quality, resistance exercise training is a reliable approach.1”
From Imaging of Sarcopenia in Type 2 Diabetes Mellitus (2024) · cites this paper as [1]
In the citing paper
“This is of particular concern in older adults, where muscle loss contributes to frailty, impaired glucose regulation, increased fall risk, and decreased quality of life [33].”
From Unintended Consequences of Obesity Pharmacotherapy: A Nutritional Approach to Ensuring Better Patient Outcomes (2025) · cites this paper as [33]
In the citing paper
“fatigue and grip strength are also well-established measures of sarcopenia and physical frailty54,55 and are commonly used to assess the pathological impairment of quality of life in older people in clinical practice.”
From Trigonelline Is an NAD+ Precursor That Improves Muscle Function during Ageing and Is Reduced in Human Sarcopenia (2024) · cites this paper as [54]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Frailty in Older Adults: Evidence for a Phenotype
Fried, L. P., Tangen, C. M., Walston, J., Newman, A. B., Hirsch, C., Gottdiener, J., Seeman, T., Tracy, R., Kop, W. J., Burke, G., et al. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.3.m146 · Cited by 24,907
The Timed “Up & Go”: A Test of Basic Functional Mobility for Frail Elderly Persons
Podsiadlo, D., & Richardson, S. (1991) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1991.tb01616.x · Cited by 14,418 · cited 1×
“For the TUG test, individuals are asked to rise from a standard chair, walk to a marker 3 m away, turn around, walk back and sit down again [89].”
MethodSarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601
Self-citationClegg, A., Young, J., Iliffe, S., Rikkert, M. O., & Rockwood, K. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62167-9 · Cited by 9,503
A global clinical measure of fitness and frailty in elderly people
Rockwood, K. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.050051 · Cited by 8,968
Definition and classification of cancer cachexia: an international consensus
Fearon, K., Strasser, F., Anker, S. D., Bosaeus, I. G., Bruera, E. D., Fainsinger, R. L., Jatoi, A., Loprinzi, C. L., Macdonald, N., Mantovani, G., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70218-7 · Cited by 6,020
Gait speed and survival in older adults.
Studenski, S. (2011) · JAMA · doi:10.1001/jama.2010.1923 · Cited by 4,558 · cited 1×
“…<7.0 kg/m2 <6.0 kg/m2 Gould (2014) [125] EWGSOP2 sarcopenia cut-off points for low performance Gait speed ≤0.8 m/s Cruz-Jentoft (2010) [1] Studenski (2011) [84] SPPB ≤8 point score Pavasini (2016) [90] Guralnik (1995) [126] TUG ≥20 s Bischoff (2003) [127] 400 m walk test Non-completion…”
BackgroundInfluentialFrailty Consensus: A Call to Action
Morley, J. E., Vellas, B. J., van Kan, G. A., Anker, S. D., Bauer, J. M., Bernabei, R., Cesari, M., Chumlea, W. C., Doehner, W., Evans, J., et al. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.03.022 · Cited by 4,201
Self-citationLower-extremity function in persons over the age of 70 years as a predictor of subsequent disability
Guralnik, J. M., Ferrucci, L., Simonsick, E. M., Salive, M. E., & Wallace, R. B. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503023320902 · Cited by 4,083
Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia
Chen, L.-K., Liu, L.-K., Woo, J., Assantachai, P., Auyeung, T.-W., Bahyah, K. S., Chou, M.-Y., Chen, L.-Y., Hsu, P.-S., Krairit, O., et al. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.11.025 · Cited by 4,051
Flagged first, then by citations
2 of the 156 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Keller, 2018, Sarcopenia, Wien Med Wochenschr
Cited by
Sorted by citations
Items 201–300 of 1,118
Rheumatoid sarcopenia: loss of skeletal muscle strength and mass in rheumatoid arthritis
Bennett, J. L., Pratt, A. G., Dodds, R. M., Sayer, A. A., & Isaacs, J. D. (2023) · Nature Reviews Rheumatology · doi:10.1038/s41584-023-00921-9 · Cited by 174
Self-citationInoue, T., Maeda, K., Nagano, A., Shimizu, A., Ueshima, J., Murotani, K., Sato, K., & Tsubaki, A. (2020) · Nutrients · doi:10.3390/nu12123743 · Cited by 171
Zhang, X., Dou, Q.-L., Zeng, Y., Yang, Y., Cheng, A. S. K., & Zhang, W.-W. (2020) · BMC Cancer · doi:10.1186/s12885-020-6645-6 · Cited by 162
Chen, H., Huang, X., Dong, M., Wen, S., Zhou, L., & Yuan, X. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s410834 · Cited by 185
“It is found that persistent localization switches from subcutaneous to visceral may lead to the ectopic accumulation of adipocytes and lipids in, such as bone marrow, liver, and especially skeletal muscle.(12,27) Compared with healthy elderly individuals, diabetic patients acquire up to 3-folds of the intramuscular fa…”
BackgroundPhysical Exercise in the Oldest Old
Valenzuela, P. L., Castillo‐García, A., Morales, J. S., Izquierdo, M., Serra‐Rexach, J. A., Santos‐Lozano, A., & Lucia, A. (2019) · Comprehensive Physiology · doi:10.1002/cphy.c190002 · Cited by 152
Lim, M. T., Pan, B. J., Toh, D. W. K., Sutanto, C. N., & Kim, J. E. (2021) · Nutrients · doi:10.3390/nu13020661 · Cited by 164
“This age-related loss of muscle mass and strength is termed sarcopenia, now recognized as a “muscle disease” [10].”
BackgroundRelationship Between Sarcopenia and Cardiovascular Diseases in the Elderly: An Overview
He, N., Zhang, Y., Zhang, L., Zhang, S., & Ye, H. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.743710 · Cited by 165
Fu, H., Wang, L., Zhang, W., Lü, J., & Yang, M. J. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13149 · Cited by 166
Nardone, O. M., de Sire, R., Petito, V., Testa, A., Villani, G., Scaldaferri, F., & Castiglione, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.694217 · Cited by 159
Chen, L., Arai, H., Assantachai, P., Akishita, M., Chew, S. T. H., Dumlao, L. C., Duque, G., & Woo, J. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12981 · Cited by 194
Physical Exercise and Myokines: Relationships with Sarcopenia and Cardiovascular Complications
Barbalho, S. M., Flato, U. A. P., Tofano, R. J., Goulart, R. D. A., Guiguer, E. L., Detregiachi, C. R. P., Buchaim, D. V., Araújo, A. C., Buchaim, R. L., Reina, F. T. R., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103607 · Cited by 156
Myostatin as a Biomarker of Muscle Wasting and other Pathologies-State of the Art and Knowledge Gaps
Bączek, J., Silkiewicz, M., & Wojszel, Z. B. (2020) · Nutrients · doi:10.3390/nu12082401 · Cited by 166
New insights into the pathogenesis and treatment of sarcopenia in chronic heart failure
Yin, J., Lü, X., Qian, Z., Xu, W., & Zhou, X. (2019) · Theranostics · doi:10.7150/thno.33000 · Cited by 159
Cheng, K. Y., Chow, S. K., Hung, V. W., Wong, C. H., Wong, R. M., Tsang, C. S., Kwok, T., & Cheung, W. (2021) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12825 · Cited by 154
Zanker, J., Sim, M., Anderson, K. L. M., Balogun, S. A., Brennan-Olsen, S. L., Dent, E., Duque, G., Girgis, C. M., Grossmann, M., Hayes, A., et al. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13115 · Cited by 165
Metabolic Disorders in Menopause
Jeong, H. G., & Park, H. (2022) · Metabolites · doi:10.3390/metabo12100954 · Cited by 179
Shorter, E., Sannicandro, A. J., Poulet, B., & Goljanek‐Whysall, K. (2019) · Current Rheumatology Reports · doi:10.1007/s11926-019-0839-4 · Cited by 152
Jung, H. N., Jung, C. H., & Hwang, Y. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155557 · Cited by 163
Candow, D. G., Forbes, S. C., Chilibeck, P. D., Cornish, S. M., Antonio, J., & Kreider, R. B. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8040488 · Cited by 149
Protein Intake and Sarcopenia in Older Adults: A Systematic Review and Meta-Analysis
Coelho‐Júnior, H. J., Calvani, R., Azzolino, D., Picca, A., Tosato, M., Landi, F., Cesari, M., & Marzetti, E. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19148718 · Cited by 162
Self-citationValue-Added Opportunistic CT: Insights Into Osteoporosis and Sarcopenia
Boutin, R. D., & Lenchik, L. (2020) · American Journal of Roentgenology · doi:10.2214/ajr.20.22874 · Cited by 153
Sarcopenia is associated with hypertension in older adults: a systematic review and meta-analysis
Bai, T., Fang, F., Li, F., Ren, Y., Hu, J., & Cao, J. (2020) · BMC Geriatrics · doi:10.1186/s12877-020-01672-y · Cited by 148
Wathanavasin, W., Banjongjit, A., Avihingsanon, Y., Praditpornsilpa, K., Tungsanga, K., Eiam‐Ong, S., & Susantitaphong, P. (2022) · Nutrients · doi:10.3390/nu14194077 · Cited by 154
Associations of low handgrip strength with cancer mortality: a multicentre observational study
Zhuang, C., Zhang, F., Li, W., Wang, K., Xu, H., Song, C., Guo, Z., & Shi, H. (2020) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12614 · Cited by 155
Locatelli, J. C., Costa, J. G., Haynes, A., Naylor, L. H., Fegan, P. G., Yeap, B. B., & Green, D. J. (2024) · Diabetes Care · doi:10.2337/dci23-0100 · Cited by 152
Yoshimura, N., Muraki, S., Iidaka, T., Oka, H., Horii, C., Kawaguchi, H., Akune, T., Nakamura, K., & Tanaka, S. (2019) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-019-01012-0 · Cited by 146
Membrez, M., Migliavacca, E., Christen, S., Yaku, K., Trieu, J., Lee, A. K., Morandini, F., Giner, M. P., Stiner, J., Makarov, M. V., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-00997-x · Cited by 148
“…of muscle function used do not always directly translate to human performance, fatigue and grip strength are also well-established measures of sarcopenia and physical frailty 54,55 and are commonly used to assess the pathological impairment of quality of life in older people in clinical practice.”
BackgroundSarcopenia in patients with colorectal cancer: A comprehensive review
Fernández, O. V., Trejo-Ávila, M. E., & Salgado‐Nesme, N. (2020) · World Journal of Clinical Cases · doi:10.12998/wjcc.v8.i7.1188 · Cited by 154
Muscular Strength and Cardiovascular Disease
Carbone, S., Kirkman, D. L., Garten, R. S., Rodriguez‐Miguelez, P., Artero, E. G., Lee, D.-C., & Lavie, C. J. (2020) · Journal of Cardiopulmonary Rehabilitation and Prevention · doi:10.1097/hcr.0000000000000525 · Cited by 151
Strategies for minimizing muscle loss during use of incretin‐mimetic drugs for treatment of obesity
Mechanick, J. I., Butsch, W. S., Christensen, S. M., Hamdy, O., Li, Z., Prado, C. M., & Heymsfield, S. B. (2025) · Obesity Reviews · doi:10.1111/obr.13841 · Cited by 149
Sarcopenia and Cognitive Function: Role of Myokines in Muscle Brain Cross-Talk
Scisciola, L., Fontanella, R. A., Surina, S., Cataldo, V., Paolisso, G., & Barbieri, M. (2021) · Life · doi:10.3390/life11020173 · Cited by 153
Identifying and Managing Malnutrition, Frailty and Sarcopenia in the Community: A Narrative Review
Roberts, S., Collins, P. F., & Rattray, M. (2021) · Nutrients · doi:10.3390/nu13072316 · Cited by 155
Huang, Y.-H., Chiu, W.-C., Hsu, Y.-P., Lo, Y.-L., & Wang, Y.-H. (2020) · Nutrients · doi:10.3390/nu12123739 · Cited by 142
Tsekoura, M., Billis, E., Tsepis, E., Dimitriadis, Z., Matzaroglou, C., Tyllianakis, M., Panagiotopoulos, E., & Gliatis, J. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7120480 · Cited by 142
Diet for the prevention and management of sarcopenia
Calvani, R., Picca, A., Coelho‐Júnior, H. J., Tosato, M., Marzetti, E., & Landi, F. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155637 · Cited by 164
Self-citationKim, M., & Won, C. W. (2020) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2020.03.018 · Cited by 141
Experimental Models of Sarcopenia: Bridging Molecular Mechanism and Therapeutic Strategy
Mankhong, S., Kim, S., Moon, S., Kwak, H., Park, D., & Kang, J. (2020) · Cells · doi:10.3390/cells9061385 · Cited by 150
Merchant, R. A., Seetharaman, S. K., Au, L. S. Y., Wong, M. W. K., Wong, B., Tan, L. F., Chen, M. Z., Ng, S. E., Soong, J. T. Y., Hui, R. J. Y., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.765415 · Cited by 159
Cereda, E., Pisati, R., Rondanelli, M., & Caccialanza, R. (2022) · Nutrients · doi:10.3390/nu14071524 · Cited by 139
Muscle Wasting and Sarcopenia in Heart Failure—The Current State of Science
Lena, A., Anker, M. S., & Springer, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186549 · Cited by 147
Protein Intake and Frailty: A Matter of Quantity, Quality, and Timing
Coelho‐Júnior, H. J., Marzetti, E., Picca, A., Cesari, M., Uchida, M. C., & Calvani, R. (2020) · Nutrients · doi:10.3390/nu12102915 · Cited by 153
Self-citationBahat, G., Türkmen, B. Ö., Aliyev, S., Çatıkkaş, N. M., Bakır, B., & Karan, M. A. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.01.010 · Cited by 145
Self-citationInflammaging: The ground for sarcopenia?
Liang, Z., Zhang, T., Liu, H., Li, Z., Peng, L., Wang, C., & Wang, T. (2022) · Experimental Gerontology · doi:10.1016/j.exger.2022.111931 · Cited by 156
Yamada, M., Kimura, Y., Ishiyama, D., Nishio, N., Otobe, Y., Tanaka, T., Ohji, S., Koyama, S., Sato, A., Suzuki, M., et al. (2019) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.13643 · Cited by 143
Muscle wasting as an independent predictor of survival in patients with chronic heart failure
von Haehling, S., Garfias‐Veitl, T., Valentová, M., Anker, M. S., Ebner, N., Bekfani, T., Haarmann, H., Schefold, J. C., Lainščak, M., Cleland, J. G. F., et al. (2020) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12603 · Cited by 143
Chatzipetrou, V., Bégin, M., Hars, M., & Trombetti, A. (2021) · Calcified Tissue International · doi:10.1007/s00223-021-00898-1 · Cited by 140
Drapkina, O. M., Васильевна, К. А., Калинина, А. М., Avdeev, S. M., Викторович, А. М., Alexandrova, L. M., Анциферова, А. А., Dm, A., Ахмеджанов, Н. М., Balanova, Y. А., et al. (2022) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2022-3235 · Cited by 197
STAR—Sonographic Thigh Adjustment Ratio: A Golden Formula for the Diagnosis of Sarcopenia
Kara, M., Kaymak, B., Ata, A. M., Özkal, Ö., Kara, Ö., Baki, A., Şengül Ayçiçek, G., Topuz, S., Karahan, S., Soylu, A. R., et al. (2020) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0000000000001439 · Cited by 137
Sarcopenia in Chronic Liver Disease: Impact on Outcomes
Ooi, P. H., Hager, A., Mazurak, V. C., Dajani, K. Z., Bhargava, R., Gilmour, S. M., & Mager, D. R. (2019) · Liver Transplantation · doi:10.1002/lt.25591 · Cited by 130
Sepúlveda‐Loyola, W., Phu, S., Hassan, E. B., Brennan-Olsen, S. L., Zanker, J., Vogrin, S., Conzade, R., Kirk, B., Saedi, A. A., Probst, V. S., et al. (2019) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2019.09.005 · Cited by 144
Meng, Q., Tan, S., Jiang, Y., Han, J. S., Xi, Q., Zhuang, Q., & Wu, G. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.04.043 · Cited by 135
Rondanelli, M., Cereda, E., Klersy, C., Faliva, M. A., Peroni, G., Nichetti, M., Gasparri, C., Iannello, G., Spadaccini, D., Infantino, V., et al. (2020) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12532 · Cited by 135
Prokopidis, K., Giannos, P., Triantafyllidis, K. K., Kechagias, K. S., Mesinovic, J., Witard, O. C., & Scott, D. S. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12976 · Cited by 147
Sarcopenia and peripheral arterial disease: a systematic review
Pizzimenti, M., Meyer, A., Charles, A., Giannini, M., Chakfé, N., Lejay, A., & Gény, B. (2020) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12587 · Cited by 133
Sarcopenia in Autoimmune and Rheumatic Diseases: A Comprehensive Review
An, H. J., Tizaoui, K., Terrazzino, S., Cargnin, S., Lee, K. H., Nam, S. W., Kim, J., Yang, J. W., Lee, J. Y., Smith, L., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165678 · Cited by 142
Liu, D., Wang, S., Liu, S., Wang, Q., Che, X., & Wu, G. (2024) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2024.101270 · Cited by 157
Stefanakis, K., Kokkorakis, M., & Mantzoros, C. S. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156057 · Cited by 142
Takenaka, Y., Oya, R., Takemoto, N., & Inohara, H. (2021) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12755 · Cited by 136
Skeie, E., Tangvik, R. J., Nymo, L. S., Harthug, S., Lassen, K., & Viste, A. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.07.003 · Cited by 132
Cruz-Jentoft, A. J., Dawson Hughes, B., Scott, D., Sanders, K. M., & Rizzoli, R. (2020) · Maturitas · doi:10.1016/j.maturitas.2019.11.007 · Cited by 144
Self-citationSarcopenia: Current treatments and new regenerative therapeutic approaches
Lo, J. C. Y., Kin Pong, U., Yiu, T. L., Ong, M. T., & Lee, W. (2020) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2020.04.002 · Cited by 137
Keller, H., de van der Schueren, M. A. E., for the GLIM Consortium, Jensen, G. L., Barazzoni, R., Compher, C., Correia, M. I. T. D., Gonzalez, M. C., Jager‐Wittenaar, H., Pirlich, M., et al. (2020) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.1806 · Cited by 131
Self-citationFaron, A., Sprinkart, A. M., Kuetting, D. L. R., Feißt, A., Isaak, A., Endler, C., Chang, J., Nowak, S., Block, W., Thomas, D., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-68797-3 · Cited by 143
Fernandes, L. V., Paiva, A. E. G., Silva, A. C. B., Coelho, I., Santiago, A. F., de Oliveira, E. P., & Pôrto, L. C. J. (2021) · Aging Clinical and Experimental Research · doi:10.1007/s40520-021-01951-7 · Cited by 140
Screening, diagnosis and monitoring of sarcopenia: When to use which tool?
Ackermans, L. L. G. C., Rabou, J., Basrai, M., Schweinlin, A., Bischoff, S. C., Cussenot, O., Cancel‐Tassin, G., Renken, R. J., Gómez, E., González, P. S., et al. (2022) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2022.01.027 · Cited by 143
Bernhardt, A. M. J., Copeland, H., Deswal, A., Gluck, J., Givertz, M. M., Bernhardt, A. M. J., Gluck, J., Garan, A. R., Hall, S. A., Hayanga, A. J., et al. (2023) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2022.10.028 · Cited by 141
Prevalence and Associated Factors of Sarcopenia in Singaporean Adults—The Yishun Study
Pang, B. W. J., Wee, S. L., Lau, L. K., Jabbar, K. B. A., Seah, W. T., Ng, D. H. M., Tan, Q. L. L., Chen, K. K., Jagadish, M. U., & Ng, T. P. (2020) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2020.05.029 · Cited by 134
Fedele, D., Francesco, A. D., Riso, S., & Collo, A. (2020) · Nutrition · doi:10.1016/j.nut.2020.111016 · Cited by 138
Oxidative Stress and Cognitive Decline: The Neuroprotective Role of Natural Antioxidants
Franzoni, F., Scarfò, G., Guidotti, S., Fusi, J., Асомов, М. И., & Pruneti, C. A. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.729757 · Cited by 136
Sarcopenia in Menopausal Women: Current Perspectives
Buckinx, F., & Aubertin‐Leheudre, M. (2022) · International Journal of Women s Health · doi:10.2147/ijwh.s340537 · Cited by 153
Martin, L., Gioulbasanis, I., Sénesse, P., & Baracos, V. E. (2019) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.1597 · Cited by 135
Beneficial Effects of Leucine Supplementation on Criteria for Sarcopenia: A Systematic Review
Martínez‐Arnau, F. M., Fonfría-Vivas, R., & Cauli, O. (2019) · Nutrients · doi:10.3390/nu11102504 · Cited by 133
Multidimensional Approach to Frailty
Wleklik, M., Uchmanowicz, I., Jankowska, E. A., Vitale, C., Lisiak, M., Drozd, M., Pobrotyn, P., Tkaczyszyn, M., & Lee, C. S. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.00564 · Cited by 131
Lee, C., & Kang, J. (2020) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12575 · Cited by 128
Ticinesi, A., Mancabelli, L., Tagliaferri, S., Nouvenne, A., Milani, C., Rio, D. D., Lauretani, F., Maggio, M. G., Ventura, M., & Meschi, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238946 · Cited by 138
Self-citationBeaudart, C., Alcázar, J., Aprahamian, I., Batsis, J. A., Yamada, Y., Prado, C. M. M., Reginster, J., Sánchez‐Rodríguez, D., Lim, W. S., Sim, M., et al. (2025) · Aging Clinical and Experimental Research · doi:10.1007/s40520-025-02995-9 · Cited by 160
“Sarcopenia, a progressive skeletal muscle disorder characterized by the loss of muscle mass and strength, represents a significant global health burden, particularly among the aging population [1–3].”
Self-citationSarcopenia: Molecular Pathways and Potential Targets for Intervention
Pascual-Fernández, J., Fernández-Montero, A., Córdova-Martínez, A., Pastor, D., Martínez-Rodríguez, A., & Roche, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228844 · Cited by 125
Lee, Y. S., Hong, N., Witanto, J. N., Choi, Y. R., Park, J., Decazes, P., Eude, F., Kim, C. O., Kim, H. C., Goo, J. M., et al. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.06.025 · Cited by 134
Impact of sarcopenia on outcomes in surgical patients: a systematic review and meta-analysis
Knoedler, S. A., Schliermann, R., Knoedler, L., Wu, M., Hansen, F. J., Matar, D. Y., Obed, D., Vervoort, D., Haug, V., Hundeshagen, G., et al. (2023) · International Journal of Surgery · doi:10.1097/js9.0000000000000688 · Cited by 145
Espino-González, E., Dalbram, E., Mounier, R., Gondin, J., Farup, J., Jessen, N., & Treebak, J. T. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.02.014 · Cited by 141
Pancreatic Cancer and Cachexia—Metabolic Mechanisms and Novel Insights
Poulia, K., Sarantis, P., Antoniadou, D., Koustas, E., Papadimitropoulou, A., Papavassiliou, A. G., & Karamouzis, M. V. (2020) · Nutrients · doi:10.3390/nu12061543 · Cited by 133
Compher, C., Cederholm, T., Correia, M. I. T. D., Gonzalez, M. C., Higashiguch, T., Shi, H. P., Bischoff, S. C., Boirie, Y., Carrasco, F., Cruz‐Jentoft, A., et al. (2022) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.2366 · Cited by 125
Self-citationSarcopenia and fatty liver disease
Kim, J. A., & Choi, K. M. (2019) · Hepatology International · doi:10.1007/s12072-019-09996-7 · Cited by 125
Buchard, B., Boirie, Y., Cassagnes, L., Lamblin, G., Coilly, A., & Abergel, A. (2020) · Nutrients · doi:10.3390/nu12010186 · Cited by 127
Self-citationNachit, M., Horsmans, Y., Summers, R. M., Leclercq, I. A., & Pickhardt, P. J. (2023) · Radiology · doi:10.1148/radiol.222008 · Cited by 130
Common Musculoskeletal Disorders in the Elderly: The Star Triad
Minetto, M. A., Giannini, A., McConnell, R., Busso, C., Torre, G., & Massazza, G. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9041216 · Cited by 124
Therakomen, V., Petchlorlian, A., & Lakananurak, N. (2020) · Scientific Reports · doi:10.1038/s41598-020-75250-y · Cited by 130
Sarcopenic Obesity: An Emerging Public Health Problem
Ji, T., Li, Y., & Ma, L. (2022) · Aging and Disease · doi:10.14336/ad.2021.1006 · Cited by 131
Santos, L. P., Gonzalez, M. C., Orlandi, S. P., Bielemann, R. M., Barbosa‐Silva, T. G., Heymsfield, S. B., & COCONUT Study Group (2019) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.1605 · Cited by 122
Muscle Density, but Not Size, Correlates Well With Muscle Strength and Physical Performance
Wang, L., Yin, L., Zhao, Y., Su, Y., Sun, W., Chen, S., Liu, Y., Yang, M., Yu, A., Guglielmi, G., et al. (2020) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2020.06.052 · Cited by 127
Sarcopenia in Inflammatory Bowel Disease: A Narrative Overview
Dhaliwal, A., Quinlan, J. I., Overthrow, K., Greig, C. A., Lord, J. M., Armstrong, M. J., & Cooper, S. C. (2021) · Nutrients · doi:10.3390/nu13020656 · Cited by 129
Sarcopenia and frailty in individuals with dementia: A systematic review
Waite, S. J., Maitland, S., Thomas, A. J., & Yarnall, A. J. (2020) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2020.104268 · Cited by 129
Normal weight obesity and unaddressed cardiometabolic health risk—a narrative review
Wijayatunga, N. N., & Dhurandhar, E. J. (2021) · International Journal of Obesity · doi:10.1038/s41366-021-00858-7 · Cited by 125
Age- and Sex-Specific Changes in Lower-Limb Muscle Power Throughout the Lifespan
Alcázar, J., Aagaard, P., Haddock, B., Kamper, R. S., Hansen, S. K., Prescott, E., Alegre, L. M., Frandsen, U., & Suetta, C. (2020) · The Journals of Gerontology Series A · doi:10.1093/gerona/glaa013 · Cited by 142
Diet, exercise, and pharmacotherapy for sarcopenia in people with diabetes
Hashimoto, Y., Takahashi, F., Okamura, T., Hamaguchi, M., & Fukui, M. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155585 · Cited by 126
da Rocha, I. M. G., Marcadenti, A., de Medeiros, G. O. C., Bezerra, R. A., Rêgo, J. F. M., González, M. C., & Fayh, A. P. T. (2019) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12391 · Cited by 122
Frailty Factors and Outcomes in Vascular Surgery Patients
Houghton, J. S. M., Nickinson, A., Morton, A., Nduwayo, S., Pepper, C., Rayt, H. S., Gray, L. J., Conroy, S., Haunton, V. J., & Sayers, R. D. (2019) · Annals of Surgery · doi:10.1097/sla.0000000000003642 · Cited by 119
Muscaritoli, M., Arends, J., & Aapro, M. (2019) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835919880084 · Cited by 140
Huang, L., Liu, Y., Lin, T., Hou, L., Song, Q., Ge, N., & Yue, J. (2022) · BMC Geriatrics · doi:10.1186/s12877-022-03270-6 · Cited by 156
Biological basis and treatment of frailty and sarcopenia
Sato, R., Vatic, M., da Fonseca, G. W. P., Anker, S. D., & von Haehling, S. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae073 · Cited by 130
Metadata
- Authors
- Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., Schneider, S. M., Sieber, C. C., Topinkova, E., Vandewoude, M., Visser, M., Zamboni, M., Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), A. T. E. G. F. E., Bautmans, I., Baeyens, J.-P., Cesari, M., Cherubini, A., Kanis, J., Maggio, M., Martin, F., Michel, J.-P., Pitkala, K., Reginster, J.-Y., Rizzoli, R., Sánchez-Rodríguez, D., & Schols, J.
- Affiliations
- Instituto Ramón y Cajal de Investigación Sanitaria (ES)
- Istanbul University (TR)
- Heidelberg University (DE)
- Research Department, Centre Hospitalier Universitaire de Clermont-Ferrand, Clermont-Ferrand, France
- University of Liège (BE)
- Uppsala University (SE)
- University of Oxford (GB)
- Università Cattolica del Sacro Cuore (IT)
- Université de Toulouse (FR)
- Newcastle upon Tyne Hospitals NHS Foundation Trust (GB)
- Université Côte d'Azur (FR)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Department of Geriatrics, First Faculty of Medicine, Charles University and General Faculty Hospital, Prague, Czech Republic
- University of Antwerp (BE)
- Amsterdam Public Health (NL)
- University of Verona (IT)
- University of Geneva (CH)
- Vrije Universiteit Brussel (BE)
- University of Luxembourg (LU)
- University of Milan (IT)
- Istituto Nazionale di Riposo e Cura per Anziani (IT)
- University of Parma (IT)
- Department of General Practice and Primary Health Care, University of Helsinki and Helsinki University Central Hospital, Unit of Primary Health Care; Helsinki, Finland
- Geriatrics Department, Parc Salut Mar. Rehabilitation Research Group, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM). Universitat Autònoma de Barcelona, Universitat Pompeu Fabra; Barcelona, Spain
- Maastricht University (NL)
- Corresponding author
- Cruz-Jentoft, Alfonso J
- ORCID
- Cruz-Jentoft, Alfonso J
- Bahat, Gülistan
- Bauer, Jürgen
- Bruyère, Olivier
- Cederholm, Tommy
- Cooper, Cyrus
- Landi, Francesco
- Rolland, Yves
- Sayer, Avan Aihie
- Schneider, Stéphane M
- Sieber, Cornel C
- Vandewoude, Maurits
- Visser, Marjolein
- Zamboni, Mauro
- Bautmans, Ivan
- Baeyens, Jean-Pierre
- Cesari, Matteo
- Cherubini, Antonio
- Kanis, John
- Maggio, Marcello
- Martin, Finbarr
- Michel, Jean-Pierre
- Reginster, Jean-Yves
- Rizzoli, René
- Schols, Jos
- Venue
- Age and Ageing
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-09-24
- Volume
- 48
- Issue
- 1
- Pages
- 16-31
- ISSN
- 0002-0729 (ISSN-L)
- 1468-2834
- PMC
- PMC6322506
- OpenAlex
- W2897513125
- Semantic Scholar
- ccbd36e412f2f03b0db9d7628ea646fb57c093c9
- Cited by
- 13,818
- References
- 156
- Citations by year
- 2026: 1514 · 2025: 2382 · 2024: 2262 · 2023: 2122 · 2022: 1909 · 2021: 1759 · 2020: 1234 · 2019: 580 · 2018: 25
- FWCI
- 616.75
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Age and Ageing (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- VU Research Portal (publishedVersion, other-oa)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (acceptedVersion)
- Uppsala University Publications (Uppsala University) (submittedVersion, other-oa)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Research Publications (Maastricht University) (submittedVersion, cc-by-nc)
- Työväentutkimus Vuosikirja (submittedVersion)
- Università Politecnica delle Marche (Università Politecnica delle Marche) (submittedVersion)
- Lirias (submittedVersion)
- ORBi (University of Liège) (submittedVersion)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Newcastle University ePrints (Newcastle Univesity) (cc-by-nc)
- Funders
- European Working Group on Sarcopenia in Older People 2
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Keywords
- sarcopenia, sarcopenia definitions, sarcopenia diagnosis, muscle weakness, muscle mass, muscle quality, physical performance, sarcopenia severity, case-finding algorithms, cut-off values, older adults, EWGSOP2 criteria
- MeSH terms
- Europe, Humans, Biomarkers, Muscle, Skeletal, Biomedical Research, Muscle Strength, Sarcopenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
